Pharmateca
ISSN 2073-4034 (Print)
ISSN 2414-9128 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
Home
>
Search
>
Author Details
Author Details
Sychev, D. A
Issue
Section
Title
File
No 13 (2015)
Articles
Chastota naznacheniya potentsial'no ne rekomendovannykh lekarstvennykh preparatov (po kriteriyam «STOPP START») pozhilym patsientam, nakhodyashchimsya v terapevticheskikh otdeleniyakh statsionara: rezul'taty farmakoepidemiologicheskogo issledovaniya
Vol 27, No 5 (2020)
Articles
«PharmaCOVID» - information center for pharmacotherapy of patients with new coronavirus infection COVID-19
Vol 27, No 5 (2020)
Articles
Drug-induced diseases: epidemiology and urgency of the problem
Vol 27, No 6 (2020)
Articles
Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance
Vol 27, No 14 (2020)
Articles
Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19
Vol 28, No 1 (2021)
Articles
The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide
Vol 28, No 1 (2021)
Articles
Possibility and prospects of using bamlanivimab in patients with COVID-19
Vol 28, No 3 (2021)
Articles
Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system
Vol 28, No 3 (2021)
Articles
The influence of CYP2C9 gene polymorphisms on the efficacy of losartan in patients with grade I-II arterial hypertension
Vol 28, No 3 (2021)
Articles
Carriage of the COMT rs4680 polymorphic variant is associated with better tolerance to antipsychotics in adolescents with an acute psychotic episode: a prospective observational clinical study
Vol 28, No 5 (2021)
Articles
Tobacco smoking as a risk factor for the development of drug-induced diseases
Vol 28, No 9 (2021)
Articles
Polymorphic variants of the ANKS1B rs7968606 (C>T) and ZNF804A rs1344706 (G>T) genes are not associated with the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
Vol 28, No 9 (2021)
Articles
HTR2A rs6313 polymorphic variant is associated with adverse effects to antipsychotics in adolescents with an acute psychotic episode
Vol 28, No 10 (2021)
Articles
Potentials for the use of glucocorticosteroids in inpatients with severe COVID-19
Vol 28, No 11 (2021)
Articles
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors
Vol 28, No 11 (2021)
Articles
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
Vol 28, No 11 (2021)
Articles
Medication errors as risk factor for drug-induced diseases
Vol 28, No 12 (2021)
Articles
Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19
Vol 28, No 12 (2021)
Articles
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
Vol 28, No 13 (2021)
Articles
Drug-alcohol interactions: focus on central-acting drugs and analgesics
Vol 28, No 13 (2021)
Articles
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs
Vol 28, No 13 (2021)
Articles
Effect of CYP2C9 gene polymorphism on losartan dosage regimen in patients with I-II degree arterial hypertension
Vol 29, No 1 (2022)
Articles
Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions
Vol 29, No 3 (2022)
Articles
Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence
Vol 29, No 3 (2022)
Articles
Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status
Vol 29, No 13 (2022)
Articles
Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP